Verition Fund Management
VERA icon

Verition Fund Management’s Vera Therapeutics VERA Stock Holding History

Verition Fund Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,877
Closed -$1.19M – 3979
2025
Q3 		$1.19M Buy
+40,877
New +$945K ﹤0.01% 2396
2025
Q2 		– Sell
-42,769
Closed -$1.03M – 3884
2025
Q1 		$1.03M Buy
42,769
+20,874
+95% +$671K ﹤0.01% 2110
2024
Q4 		$926K Sell
21,895
-21,315
-49% -$944K ﹤0.01% 2103
2024
Q3 		$1.91M Buy
+43,210
New +$1.64M 0.01% 1446

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Verition Fund Management's VERA Position: Q4 2025 in Review

Verition Fund Management sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 40,877 shares — an estimated $1.19M sold.

Verition Fund Management first reported a position in VERA in Q3 2024 and held it in 4 quarters. The position peaked at $1.91M in Q3 2024. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Verition Fund Management reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 40,877 Vera Therapeutics shares in Q4 2025, an estimated $1.19M.
  • Verition Fund Management first reported a position in Vera Therapeutics in Q3 2024 and held it in 4 quarters.
  • Verition Fund Management's Vera Therapeutics position peaked at $1.91M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.